Code of Maine Rules
10 - DEPARTMENT OF HEALTH AND HUMAN SERVICES
144 - DEPARTMENT OF HEALTH AND HUMAN SERVICES - GENERAL
Chapter 101 - MAINECARE BENEFITS MANUAL (FORMERLY MAINE MEDICAL ASSISTANCE MANUAL)
Chapter I - Specific Policies By Service
Sec2 144-101-I-5 - COVID-19 Public Health Emergency Services
Subsection 144-101-I-5.04 - PHARMACY SERVICES
Current through 2024-38, September 18, 2024
The Department alters certain provisions of the MBM, Section 80, Pharmacy Services, as follows:
A. Initial Prior Authorization requirements for asthma and immune-related prescriptions: Restrictions on asthma related medications like Albuterol are removed to allow all forms of Albuterol without Prior Authorization. Restrictions on Immune-related medications, like Neupogen, are removed for approval with completion of Prior Authorization form, if necessary, for the treatment of COVID-19.
B. COVID-19 Treatments or Vaccines: Should COVID-19 specific treatments or vaccines become available during the duration of this emergency rule, Prior Authorization will be waived.
C. Prescription Refills: Early refills of prescription medications are allowed in the same days' supply and quantity as the original prescription; the requirements set forth in Ch. II, Sec. 80.07-7 are waived.
D. Buprenorphine and Buprenorphine Combination Products for Substance Use Disorder (SUD): The physical assessment requirements for Buprenorphine and Buprenorphine Combination Products for SUD set forth in Ch. II, Sec. 80.07-13 are waived.
